Merck and Endocyte Announce European CHMP Positive Opinions for VYNFINITÂ® (vintafolide) and Companion Imaging Agents FOLCEPRIÂ® (etarfolatide) and NEOCEPRIÂ® (Intravenous (IV) folic acid) in Patients with Platinum-Resistant